All Stories

  1. From Bench to Bedside: The Clinical Relevance of Atrial Electrical Remodeling in Atrial Fibrillation Therapy
  2. Management of patients with atrial tachycardia: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Hea...
  3. Closing Editorial for the Special Issue: Cardiac Electrophysiology and Catheter Ablation of Different Arrhythmias
  4. The functional substrate in patients with atrial fibrillation is predictive of recurrences after catheter ablation
  5. Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device’s patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC
  6. Induction of ventricular fibrillation during programmed ventricular stimulation in a patient with CASQ2 heterozygous mutation
  7. Comparison of Electrical Conductivity and Schottky Behavior of 4‐[2‐(9‐anthryl)vinyl]pyridine Based Two 1D Coordination Polymers of Zn(II) and Cd(II)
  8. High-resolution mapping of reentrant atrial tachycardias: Relevance of low bipolar voltage
  9. Incessant ventricular tachycardia with simultaneous recording of separate exits with common isthmus wavefront propagation
  10. Significance of abnormal and late ventricular signals in ventricular tachycardia ablation of ischemic and nonischemic cardiomyopathies
  11. Step by Step through the Years—High vs. Low Energy Lead Extraction Using Advanced Extraction Techniques
  12. Bipolar Radiofrequency Catheter Ablation for Ventricular Arrhythmias
  13. Sinus node exit, crista terminalis conduction, interatrial connection, and wavefront collision: Key features of human atrial activation in sinus rhythm
  14. Slow Conduction Corridors and Pivot Sites Characterize the Electrical Remodeling in Atrial Fibrillation
  15. Bi‐atrial characterization of the electrical substrate in patients with atrial fibrillation
  16. Modern mapping and ablation of idiopathic outflow tract ventricular arrhythmias
  17. Working on the dirty side—the ipsilateral subclavian access for temporary pacing after lead extraction
  18. Electrogram fractionation during sinus rhythm occurs in normal voltage atrial tissue in patients with atrial fibrillation
  19. Effect of electrode size and spacing on electrograms: Optimized electrode configuration for near-field electrogram characterization
  20. Amiodarone in ventricular arrhythmias: still a valuable resource?
  21. Outcome of left atrial appendage closure using cerebral protection system for thrombosis: no patient left behind
  22. Long-term outcome of left atrial appendage occlusion with multiple devices
  23. Epicardial course of the musculature related to the great cardiac vein: Anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion
  24. Right ventricular outflow tract electroanatomical abnormalities in asymptomatic and high‐risk symptomatic patients with Brugada syndrome: Evidence for a new risk stratification tool?
  25. The RV1-V3 transition ratio: A novel electrocardiographic criterion for the differentiation of right versus left outflow tract premature ventricular complexes
  26. Check the Need–Prevalence and Outcome after Transvenous Cardiac Implantable Electric Device Extraction without Reimplantation
  27. Left Ventricular Unloading With an IABP in Patients Undergoing Ventricular Tachycardia Ablation With ECMO Support
  28. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy
  29. A Computational Study of the Electrophysiological Substrate in Patients Suffering From Atrial Fibrillation
  30. Landing on the spot: Approaches to outflow tract PVCs; from ECG to EGMs to intracardiac echocardiography
  31. Automated rhythm-based control of radiofrequency ablation close to the atrioventricular node: Preclinical, animal, and first-in-human testing
  32. Ligament of Marshall ablation for persistent atrial fibrillation
  33. Characterization of cardiac electrogram signals in atrial arrhythmias
  34. Novel technique targeting left ventricular summit premature ventricular contractions using radiofrequency ablation through a guidewire
  35. Epicardial course of the septopulmonary bundle: Anatomical considerations and clinical implications for roof line completion
  36. Ante-mortem characterization of sudden deaths as first-manifestation in Italy
  37. Ultralow temperature cryoablation: Safety and efficacy of preclinical atrial and ventricular lesions
  38. Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long‐term results and clinical outcomes
  39. Use of high-density activation and voltage mapping in combination with entrainment to delineate gap-related atrial tachycardias post atrial fibrillation ablation
  40. Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: Safety and efficacy in a pilot cohort study
  41. Smartwatch-detected atrial fibrillation in the Emergency Department: possible implications and treatment
  42. Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis
  43. Outer loop and isthmus in ventricular tachycardia circuits: Characteristics and implications
  44. Complete Electroanatomic Imaging of the Diastolic Pathway Is Associated With Improved Freedom From Ventricular Tachycardia Recurrence
  45. Impedance, power, and current in radiofrequency ablation: Insights from technical, ex vivo, and clinical studies
  46. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy
  47. Regional air pollution persistence links to COVID-19 infection zoning
  48. Severe air pollution links to higher mortality in COVID-19 patients: The “double-hit” hypothesis.
  49. The importance of electrical mapping of VT in the approaching era of clinical imaging
  50. Characterization of Complex Atrial Tachycardia in Patients With Previous Atrial Interventions Using High-Resolution Mapping
  51. Enhancing citizens response to out-of-hospital cardiac arrest: A systematic review of mobile-phone systems to alert citizens as first responders
  52. High-Density Characterization of the Ventricular Electrical Substrate During Sinus Rhythm in Post–Myocardial Infarction Patients
  53. Acute and mid-term outcome of ethanol infusion of vein of Marshall for the treatment of perimitral flutter
  54. Atrial tachycardia circuits include low voltage area from index atrial fibrillation ablation relationship between RF ablation lesion and AT
  55. Simultaneous endo-epicardial-high density mapping of ventricular tachycardia with the use of multi-electrode mapping catheters
  56. The COVID-19 challenge to cardiac electrophysiologists: optimizing resources at a referral center
  57. Electrogram morphology discriminators in implantable cardioverter defibrillators: A comparative evaluation
  58. Noninvasive programmed stimulation in the setting of ventricular tachycardia catheter ablation
  59. In silico analysis of the relation between conventional and high‐power short‐duration RF ablation settings and resulting lesion metrics
  60. Pizza in adults and grape in children are the most frequent causes of foreign body airway obstruction in Italy. A national media-based survey
  61. Catheter cryoablation of ventricular ectopy originating from his region
  62. Atrial fibrillation in Brugada syndrome: Current perspectives
  63. Mechanism of Recurrence of Atrial Tachycardia
  64. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular cardiomyopathy
  65. Does Ventricular Tachycardia Ablation Targeting Local Abnormal Ventricular Activity Elimination Reduce Ventricular Fibrillation Incidence?
  66. Ultra–High-Density Activation Mapping to Aid Isthmus Identification of Atrial Tachycardias in Congenital Heart Disease
  67. Three‐dimensional image integration guidance for cryoballoon pulmonary vein isolation procedures
  68. Right ventricular outflow tract low voltage areas identify the site of origin of idiopathic ventricular arrhythmias. A high‐density mapping study
  69. Grid Mapping Catheter for Ventricular Tachycardia Ablation
  70. Impact of Spacing and Orientation on the Scar Threshold With a High-Density Grid Catheter
  71. Noninvasive Mapping and Electrocardiographic Imaging in Atrial and Ventricular Arrhythmias (CardioInsight)
  72. Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry
  73. Post–Myocardial Infarction Scar With Fat Deposition Shows Specific Electrophysiological Properties and Worse Outcome After Ventricular Tachycardia Ablation
  74. The LUMIPOINT™ software: are we just at the turning point?
  75. An advanced algorithm for the online detection of abnormal and late potentials during sinus rhythm in the setting of ventricular tachycardia ablation
  76. Larger and deeper ventricular lesions using a novel expandable spherical monopolar irrigated radiofrequency ablation catheter
  77. Ethanol infusion for Marshall bundle epicardial connections in Marshall bundle related atrial tachycardias following atrial fibrillation ablation: the accessibility and success rate of ethanol infusion by using a femoral approach
  78. Are wall thickness channels defined by computed tomography predictive of isthmuses of postinfarction ventricular tachycardia?
  79. Effect of Activation Wavefront on Electrogram Characteristics During Ventricular Tachycardia Ablation
  80. Noninvasive Ventricular Programmed Stimulation
  81. Long‐Term Follow‐Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications
  82. The role of Marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation
  83. Insights from atrial surface activation throughout atrial tachycardia cycle length: A new mapping tool
  84. A simple mechanism underlying the behavior of reentrant atrial tachycardia during ablation
  85. Use of Novel Electrogram “Lumipoint” Algorithm to Detect Critical Isthmus and Abnormal Potentials for Ablation in Ventricular Tachycardia
  86. Substrate Mapping and Ablation for Ventricular Tachycardia in Patients with Structural Heart Disease: How to Identify Ventricular Tachycardia Substrate
  87. Fast and safe mapping of ventricular tachycardia in patient with left ventricular assist device
  88. Detailed Analysis of the Relation Between Bipolar Electrode Spacing and Far- and Near-Field Electrograms
  89. Idiopathic Ventricular Fibrillation and Otherwise Normal Electrocardiograms
  90. Early Repolarization Syndrome: Diagnostic and Therapeutic Approach
  91. Depolarization versus repolarization abnormality underlying inferolateral J wave syndromes – new concepts in sudden cardiac death with apparently normal hearts
  92. Characterizing localised reentry with high resolution mapping: evidence for multiple slow conducting isthmuses within the circuit.
  93. Response to cardiac resynchronization therapy is determined by intrinsic electrical substrate rather than by its modification
  94. Detailed comparison between the wall thickness and voltages in chronic myocardial infarction
  95. Targeted ablation of specific electrogram patterns in low-voltage areas after pulmonary vein antral isolation in persistent atrial fibrillation: Termination to an organized rhythm reduces atrial fibrillation recurrence
  96. Atrial Fibrillation Mechanisms and Implications for Catheter Ablation
  97. High-density characterization of a localized reentry circuit occurred after AF ablation
  98. Characteristics of Scar-Related Ventricular Tachycardia Circuits Using Ultra-High-Density Mapping
  99. High-power short-duration versus standard radiofrequency ablation: Insights on lesion metrics
  100. Mapping and Ablation of Idiopathic Ventricular Fibrillation
  101. Chronic Total Coronary Occlusion and Ventricular Tachycardia
  102. Influence of contact force on voltage mapping: A combined magnetic resonance imaging and electroanatomic mapping study in patients with tetralogy of Fallot
  103. Transient under-sensing of the ventricular lead during abdominal ultrasound as cause of ventricular fibrillation
  104. Impairment of the antegrade fast pathway in patients with atrioventricular nodal reentrant tachycardia can be functional and treated by slow pathway ablation: a case report study
  105. Importance of bipolar electrode orientation on local electrogram properties
  106. First clinical use of novel ablation catheter incorporating local impedance data
  107. Comprehensive Multicenter Study of the Common Isthmus in Post–Atrial Fibrillation Ablation Multiple-Loop Atrial Tachycardia
  108. Atrial tachycardia originating from deep septum following catheter ablation for persistent atrial fibrillation
  109. Universal ventricular coordinates: A generic framework for describing position within the heart and transferring data
  110. Revisiting anatomic macroreentrant tachycardia after atrial fibrillation ablation using ultrahigh-resolution mapping: Implications for ablation
  111. Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients
  112. Characteristics of Single-Loop Macroreentrant Biatrial Tachycardia Diagnosed by Ultrahigh-Resolution Mapping System
  113. Long-Term Outcome of Substrate Modification in Ablation of Post–Myocardial Infarction Ventricular Tachycardia
  114. OUP accepted manuscript
  115. Relationship Between Fibrosis Detected on Late Gadolinium-Enhanced Cardiac Magnetic Resonance and Re-Entrant Activity Assessed With Electrocardiographic Imaging in Human Persistent Atrial Fibrillation
  116. Frontiers in non-invasive cardiac mapping: future implications for arrhythmia treatment
  117. Atrial tachycardias: Cause or effect with ablation of persistent atrial fibrillation?
  118. The electrical circuit of a hemodynamically unstable and recurrent ventricular tachycardia diagnosed in 35 s with the Rhythmia mapping system
  119. Diagnostic yield of cardiovascular magnetic resonance in young-middle aged patients with high-grade atrio-ventricular block
  120. Electrogram signature of specific activation patterns: analysis of atrial tachycardias at high-density endocardial mapping.
  121. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing
  122. Dual loop reentrant tachycardia with a combination of a localized reentry and a macro-reentry
  123. Catheter Ablation for Ventricular Tachycardia in Patients with Nonischemic Cardiomyopathy
  124. Myocardial wall thinning predicts transmural substrate in patients with scar-related ventricular tachycardia
  125. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians
  126. Triple-loop reentrant atrial tachycardia originated after pulmonary vein isolation
  127. Accuracy of the pacemaker-mediated tachycardia algorithm in Boston Scientific devices
  128. Impact of New Technologies and Approaches for Post–Myocardial Infarction Ventricular Tachycardia Ablation During Long-Term Follow-Up
  129. Performance of a specific algorithm to minimize right ventricular pacing: A multicenter study
  130. Atrioventricular Reciprocating Tachycardia Mediated by Twin Atrioventricular Nodes
  131. Smart-watches: a potential challenger to the implantable loop recorder?
  132. Incremental diagnostic role of cardiac MRI in young-middle aged patients with high-grade atrio-ventricular block
  133. Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy
  134. Vagal atrial fibrillation: What is it and should we treat it?
  135. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis
  136. Transcoronary ethanol ablation for incessant ventricular tachycardia: a salvage technique when faced with left ventricular thrombus
  137. Demographic and Clinical Characteristics to Predict Paroxysmal Atrial Fibrillation: Insights from an Implantable Loop Recorder Population
  138. Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?
  139. Clinical Predictors of Pacemaker Implantation in Patients with Syncope Receiving Implantable Loop Recorder with or without ECG Conduction Abnormalities
  140. TakoTsubo cardiomyopathy: unravelling the malignant consequences of a benign disease with cardiac magnetic resonance
  141. New strategies for ventricular tachycardia and ventricular fibrillation ablation
  142. Response to Letter Regarding “Catheter Ablation of Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction: A Systematic Review and Meta-Analysis”
  143. Body Surface Mapping to Guide Atrial Fibrillation Ablation
  144. Implantable Cardioverter Defibrillators in Octogenarians: Clinical Outcomes From a Single Center
  145. Catheter Ablation of Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction
  146. The Association Between ICD Interventions and Mortality is Independent of their Modality: Clinical Implications
  147. A case of malignant arrhythmia in Takotsubo Cardiomyopathy
  148. Prevalence and significance of early repolarization in patients presenting with syncope
  149. Premature ventricular beats initiate recurrent ventricular fibrillation in early repolarization syndrome
  150. Screening for atrial fibrillation in patients with obstructive sleep apnoea to reduce ischaemic strokes
  151. Cardiac arrest in concomitant Wolff-Parkinson-White syndrome and early repolarisation: is pathway ablation enough?
  152. Prevalence of J-Point Elevation in Families With Sudden Arrhythmic Death Syndrome
  153. Cardiac myxoma presenting with sensory neuropathy
  154. Lead extraction: a new effective tool to overcome fibrous binding sites